Coloplast A/S Stock Forecast for 2023 - 2025 - 2030
Updated on 04/18/2024
Coloplast A/S Stock Forecast and Price Target
Coloplast A/S's most recent price target of kr910.00 for 2024 was provided by five renowned analysts over the past few months, with an average prediction of kr910.00. If this prediction is correct, Coloplast A/S's stock could rise by 1.07 percent from its current trading price. The potential increase for the stock is kr910.00 per share, with a possible range of kr700.00 to kr1060.00. If you want to invest in COLO B stock, you might also want to take a look at how its competitors are doing.
1.07% Upside
Coloplast A/S Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, Coloplast A/S's Price has decreased from kr789.95 to kr0.00 – a 100.00% drop! In the next year, analysts believe that Fair Value will reach kr1008.82 – an increase of 100.00%. For the next seven years, experts predict that Coloplast A/S's Fair Value will grow at a rate of 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| PG Stock Forecast | Procter & Gamble | Outperform |
12
|
$156.96 | Buy/Sell | $166.80 | 9.86% |
| JNJ Stock Forecast | Johnson & Johnson | Outperform |
9
|
$144.77 | Buy/Sell | $174.55 | 17.43% |
| PFE Stock Forecast | Pfizer | Outperform |
2
|
$25.42 | Buy/Sell | $32.87 | 19.98% |
| ULVR Stock Forecast | Unilever PLC | Hold |
8
|
£37.38 | Buy/Sell | £50.61 | 32.85% |
| SAN Stock Forecast | Sanofi | Outperform |
16
|
86.18€ | Buy/Sell | 102.80€ | 25.32% |
Coloplast A/S Revenue Forecast for 2023 - 2025 - 2030
Coloplast A/S's Revenue has grown In the last three years, rising from kr18.54B to kr24.50B – a growth of 32.12%. In the next year, analysts believe that Revenue will reach kr27.65B – an increase of 12.84%. For the next seven years, experts predict that Coloplast A/S's Revenue will grow at a rate of 77.70%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| BMY Stock Forecast | Bristol-Myers Squibb | Hold |
2
|
$47.84 | Buy/Sell | $58.15 | 14.97% |
| RKT Stock Forecast | Reckitt Benckiser Group | Outperform |
12
|
£41.10 | Buy/Sell | £66.68 | 39.90% |
| BEI Stock Forecast | Beiersdorf | Outperform |
17
|
133.95€ | Buy/Sell | 137.41€ | 11.24% |
.jpg)
Coloplast A/S Dividend per Share Forecast for 2023 - 2025 - 2030
Coloplast A/S's Dividend per Share has seen impressive growth In the last three years, rising from kr18.00 to kr21.00 – a growth of 16.67%. In the next year, analysts believe that Dividend per Share will reach kr21.24 – an increase of 1.14%. For the next seven years, the forecast is for Dividend per Share to grow by 33.05%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| BAYN Stock Forecast | Bayer | Hold |
5
|
26.25€ | Buy/Sell | 45.15€ | 21.90% |
| CLX Stock Forecast | Clorox Co-The | Hold |
16
|
$142.34 | Buy/Sell | $154.18 | 8.89% |
| SN. Stock Forecast | Smith & Nephew | Outperform |
18
|
£9.60 | Buy/Sell | £16.09 | 70.94% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| CTEC Stock Forecast | ConvaTec Group PLC | Outperform |
16
|
£2.81 | Buy/Sell | £3.43 | 40.93% |
| HYPE3 Stock Forecast | Hypera | Outperform |
16
|
R$28.30 | Buy/Sell | R$45.97 | 45.76% |
| PRGO Stock Forecast | Perrigo Co PLC | Outperform |
16
|
$30.04 | Buy/Sell | $44.75 | 33.16% |
Coloplast A/S EBITDA Forecast for 2023 - 2025 - 2030
In the last three years, Coloplast A/S's EBITDA has grown, moving from kr6.45B to kr7.57B – an increase of 17.33%. In the next year, analysts predict that EBITDA will jump to kr8.84B – up 16.84% from the current level. Looking ahead to seven years, experts forecast that EBITDA will grow by 57.13%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| AXNX Stock Forecast | Axonics | Hold |
7
|
$67.20 | Buy/Sell | $70.15 | 5.65% |
| IART Stock Forecast | Integra LifeSciences Holdings | Hold |
16
|
$31.94 | Buy/Sell | $46.60 | 36.19% |
| ORGO Stock Forecast | Organogenesis Holdings | Outperform |
10
|
$2.79 | Buy/Sell | $4.75 | 79.21% |
Coloplast A/S EBIT Forecast for 2023 - 2025 - 2030
In the last three years, Coloplast A/S's EBIT has seen an increase, rising from kr5.85B to kr6.85B. This represents a growth of 17.14%. Analysts predict that Coloplast A/S's EBIT will increase in the upcoming year, reaching kr7.92B. This would represent an increase of 15.65%. Over the next seven years, experts predict that Coloplast A/S's EBIT will grow at a rate of 97.07%.
Coloplast A/S EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, Coloplast A/S's EPS has decreased from kr19.67 to kr0.00 – a 100.00% drop! In the next year, analysts believe that EPS will reach kr25.12 – an increase of 100.00%. For the next seven years, experts predict that Coloplast A/S's EPS will grow at a rate of 100.00%.
.jpg)